SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-14-448649
Filing Date
2014-12-19
Accepted
2014-12-19 16:20:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d840659d424b5.htm 424B5 265776
2 GRAPHIC g840659001.jpg GRAPHIC 2665
3 GRAPHIC g840659g88c63.jpg GRAPHIC 2665
  Complete submission text file 0001193125-14-448649.txt   274408
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-194956 | Film No.: 141299866
SIC: 2834 Pharmaceutical Preparations